NEUROTRANSMITTERS 22
intro
leuchter (2002)
d
e
a
c
s
neurotransmission is a process that sees different chemicals released across a synapse between two neurons that can affect behaviour or mood
neurotransmitters are chemicals that travel across a synapse that are released in the brain that can affect the behaviour or mood of an individual
acetylcholine (excitatory [increase likelihood that neuron will fire second action potential in post- neuron] , used in spatial memory)
serotonin (inhibitory [decreased likelihood of second action potential] , involved in emotion and mood and regulates processes)
neurotransmitters travel across the synaptic cleft (gap between pre and post-synaptic neuron), neuron is activated by action potential which allows vesicles to move, fuse to pre- membrane and release neurotransmitters across cleft, receptors on post- absorb neuro- and these can then be excited by a second action potential
detailed account / balanced review
jacobsen (2012), rogers and kesner (2003), leuchter (2002)
jacobsen (2012)
rm
p
aim
f
linking
ct
to investigate the role of serotonin on depressive symptoms in mice
lab experiment
highly controlled conditions where accurate measurements are possible, participants are randomly allocated to the IV
jacobsen et al conducted a meta-review that has demonstrated that low serotonin biomarkers have repeatedly been reported in depressed patients, researchers genetically modified the make-up of mice so they had a deficiency in serotonin
mice had reduced basal and stimulated levels of serotonin and demonstrated somatic symptoms of depression (signif. weight loss/gain, insomnia/hypersomnia), also more likely to act aggressively toward researcher/other mice
Jacobsen et al demonstrates the effect of 5-HT (serotonin) on depressive symptoms. For example, the mice genetically modified without the 5-HT gene showed somatic symptoms of depression. This is important because it supports the 5-HT deficiency theory that states low levels of neurotransmitters in the brain can lead to mental abnormalities such as depression. Therefore...
strength
weakness
generalisability; both humans and mice have serotonin
low repeatability; can't gm humans
rogers and kesner (2003)
aim
rm
p
f
linking
ct
to determine the role of acetylcholine in the formation of spatial memory
lab experiment
highly controlled conditions where accurate measurements are possible, participants randomly allocated to the IV
30 rats acclimate to a Hebb Williams maze by placing food in one of the corners. Rats randomly allocated to one of two conditions: injected with scopolamine (blocks acetylcholine receptors) or saline solution (placebo, control) directly into the hippocampus 10 minutes before running the maze. Encoding of memory (STM) assessed by average errors made on first 5 trials on day 1 compared to last 5 on day 1. Average number on errors made in first 5 trials compared to last 5 on day 2 to assess retrieval (LTM)
scopolamine group (experimental) took longer and made more mistakes in learning of the maze however did not appear to have an effect on retrieval
Rogers and Kesner demonstrate the effect of acetylcholine on visuo-spatial memory. For example, the rats injected with scopolamine made more mistakes on day 1 in comparison to the rats injected with a saline solution. This is important because it shows that acetylcholine is needed for the encoding (formation) of visuo-spatial memory as an excitatory neurotransmitter in the brain. Therefore, neurotransmitters have an effect on behaviour.
strength
weakness
high internal validity; the controlled variables, hebb williams maze
low mundane realism; hebb williams maze is not a usual activity for rats, however they do navigate sewers etc
aim
rm
p
f
linking
ct
to investigate changes in brain function of depressed subjects during treatment with placebo
field experiment
51 patients with depression who either received placebo or an active antidepressant medication. as EEG was used to compare brain function in the two experimental groups, design was double-blind (participants nor examiner knew who received what) and ran over 9 weeks (2-4 weeks to work). Two SSRIs (antidepressants) randomly allocated to participants
placebo group = significant increase in prefrontal cortex (emotion) activity nearly from beginning, SSRIs group different pattern but both groups got better
Leuchter demonstrates the role of serotonin on mood. For example, the depressed patients who took SSRIs, which increase the uptake of serotonin, experienced a decrease in depressive symptoms. This is important because it supports the idea that serotonin regulates mood and therefore that neurotransmitters have an effect on behaviour as patients who took SSRIs got better. Therefore, neurotransmitters have an effect on behaviour
strength
weakness
very low researcher bias
double-blind, randomly allocated SSRIs
participant variables - individual differences